Routine blood tests, biochemical, and immunological parameters. by Songyan Zou (11399489)

Subjects:

Demographics and clinical features of healthy controls and primary Sjögren’s Syndrome patients. by Songyan Zou (11399489)

Subjects:

Anonymized clinical datasets (patient demographics, medical imaging, and laboratory test records). by Songyan Zou (11399489)

Subjects:

Correlation between biochemical indicators and Lymphocyte subsets in pSS patients. by Songyan Zou (11399489)

Subjects:

Correlation between immune function indicators and Lymphocyte subsets in pSS patients. by Songyan Zou (11399489)

Subjects:

Adult <i>Shroom3</i>^<i>+</i>^<i>/Gt</i> hearts show decreased cardiomyocyte cross-sectional area. by Jennifer L. Carleton (22208916)

Subjects:

Protein-protein interaction network and hub genes. by Wei He (131453)

Subjects:

Autoignition Characteristics of NH₃/C₂H₆ Mixtures over Wide Pressure Ranges by Yueying Liang (14418450)

Subjects:

Autoignition Characteristics of NH₃/C₂H₆ Mixtures over Wide Pressure Ranges by Yueying Liang (14418450)

Subjects:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

Subjects:

Mod localizes both within and outside the nucleolus in NBs. by Amalia S. Parra (4173004)

Subjects:

Loss of Mod causes cell cycle defects. by Amalia S. Parra (4173004)

Subjects:

Frequency of tobacco smoking among smokers. by Prasanna Herath (20714794)

Subjects:

Correlation of lung function parameters with smoking variables. by Prasanna Herath (20714794)

Subjects:

Anthropometric characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75). by Prasanna Herath (20714794)

Subjects:

Lung function parameters between smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

S2 File - Factors influencing effective decrease of controlled attenuation parameters in metabolic-associated steatotic liver disease: A multilevel linear regression analysis at Va... by Sonsawan Sangprasert (22772538)

Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate). by Manal A. Alossaimi (10269852)

“…<p>Charts revealing A) the significant decrease (<i>p</i> < 0.05) in the membrane integrity and B) the significant increase (<i>p</i> < 0.05) in the membrane permeability after treatment with harmalacidine hydrochloride in a representative <i>S. aureus</i> isolate (n = 3 as technical repeats of the same isolate).…”